The upregulation of (C-X-C motif) receptor 3 (CXCR3) and its ligand (C-X-C motif) ligand (CXCL)10 (CXCL10) has been documented in many autoimmune disorders. Many studies have suggested that the CXCL10/CXCR3 axis plays a critical role in the autoimmune process and in β-cell destruction in Type 1 Diabetes (T1D). Serum CXCL10 level "Th1 chemokine" is high in T1D patients, and this suggests that CXCL10 may be a candidate for a predictive marker of T1D. Furthermore, serum CXCL10 levels measurement may be useful to assess the pathophysiology of the disease course in T1D. Blocking of the CXCL10 chemokine expression in newly onset of diabetes seems to be a possible approach for the therapy of T1D. Further studies are needed to investigate interactions between chemokines and cytokines in the pathogenesis of T1D.

Type 1 diabetes and (C-X-C motif) ligand (CXCL) 10 chemokine / Corrado, A; Ferrari, Silvia Martina; Ferri, Clodoveo; Ferrannini, E; Antonelli, A; Fallahi, P.. - In: LA CLINICA TERAPEUTICA. - ISSN 1972-6007. - STAMPA. - 165:(2014), pp. e181-185. [10.7471/CT.2014.1706]

Type 1 diabetes and (C-X-C motif) ligand (CXCL) 10 chemokine

FERRARI, Silvia Martina;FERRI, Clodoveo;
2014

Abstract

The upregulation of (C-X-C motif) receptor 3 (CXCR3) and its ligand (C-X-C motif) ligand (CXCL)10 (CXCL10) has been documented in many autoimmune disorders. Many studies have suggested that the CXCL10/CXCR3 axis plays a critical role in the autoimmune process and in β-cell destruction in Type 1 Diabetes (T1D). Serum CXCL10 level "Th1 chemokine" is high in T1D patients, and this suggests that CXCL10 may be a candidate for a predictive marker of T1D. Furthermore, serum CXCL10 levels measurement may be useful to assess the pathophysiology of the disease course in T1D. Blocking of the CXCL10 chemokine expression in newly onset of diabetes seems to be a possible approach for the therapy of T1D. Further studies are needed to investigate interactions between chemokines and cytokines in the pathogenesis of T1D.
2014
165
e181
185
Type 1 diabetes and (C-X-C motif) ligand (CXCL) 10 chemokine / Corrado, A; Ferrari, Silvia Martina; Ferri, Clodoveo; Ferrannini, E; Antonelli, A; Fallahi, P.. - In: LA CLINICA TERAPEUTICA. - ISSN 1972-6007. - STAMPA. - 165:(2014), pp. e181-185. [10.7471/CT.2014.1706]
Corrado, A; Ferrari, Silvia Martina; Ferri, Clodoveo; Ferrannini, E; Antonelli, A; Fallahi, P.
File in questo prodotto:
File Dimensione Formato  
Corrado diabete 1.pdf

Solo gestori archivio

Descrizione: articolo finale
Tipologia: Versione pubblicata dall'editore
Dimensione 107.6 kB
Formato Adobe PDF
107.6 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1063903
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 23
  • ???jsp.display-item.citation.isi??? ND
social impact